Pure Global

Clinical Trial - Trial ChiCTR2100048837

Access comprehensive clinical trial information for ChiCTR2100048837 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology and is currently Recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2100048837
Early Phase 1
Recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2100048837
View on Chinese Clinical Trial Registry
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
Analysis of the long term characteristics of SARS CoV 2 specific immunity and establishment of the accurate evaluation in COVID 19 inactivative vaccinated recipients

Study Focus

Sponsor & Location

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

the Fundamental Research Funds for the Central Universities

China

Timeline & Enrollment

Early Phase 1

N/A

Dec 01, 2024

ICD-10 Classifications

COVID-19, virus identified
Viral pneumonia, unspecified
Other viral pneumonia
COVID-19, virus not identified
Pneumonia in viral diseases classified elsewhere

Data Source

Chinese Clinical Trial Registry

ChiCTR2100048837

Non-Device Trial